Emergent Health Corp (EMGE)
EMGE Stock Price Chart
Explore Emergent Health Corp interactive price chart. Choose custom timeframes to analyze EMGE price movements and trends.
EMGE Company Profile
Discover essential business fundamentals and corporate details for Emergent Health Corp (EMGE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Sept 2009
Employees
6.00
CEO
James W. Zimbler
Description
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.
EMGE Financial Timeline
Browse a chronological timeline of Emergent Health Corp corporate events including earnings releases, dividend announcements, and stock splits.
EMGE Stock Performance
Access detailed EMGE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.